ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

This study has been completed.
Study NCT00003017.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00003017


Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center    
      Boston, Massachusetts, United States, 02215
United States, New Jersey
CCOP - Northern New Jersey    
      Hackensack, New Jersey, United States, 07601
Hunterdon Regional Cancer Center    
      Flemington, New Jersey, United States, 08822
United States, New York
Albert Einstein Comprehensive Cancer Center    
      Bronx, New York, United States, 10461
NYU School of Medicine's Kaplan Comprehensive Cancer Center    
      New York, New York, United States, 10016
University of Rochester Cancer Center    
      Rochester, New York, United States, 14642
United States, Pennsylvania
Fox Chase Cancer Center    
      Philadelphia, Pennsylvania, United States, 19111
University of Pittsburgh Cancer Institute    
      Pittsburgh, Pennsylvania, United States, 15213
United States, Tennessee
Vanderbilt Cancer Center    
      Nashville, Tennessee, United States, 37232-6838

Sponsors and Collaborators
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Investigators
Study Chair:     Scott Wadler, MD     Albert Einstein College of Medicine of Yeshiva University    





Links to all studies - primarily for crawlers